TITLE

RENAL FAILURE AND PERSISTENT HYPERTENSION IN A CHILD PRENATALLY EXPOSED TO LOSARTAN

AUTHOR(S)
AURITI, Cinzia; PIERSIGILLI, Fiammetta; MARROCCO, Gabriella; HAYWOOD LOMBARDI, Mary; DOTTA, Andrea
PUB. DATE
October 2013
SOURCE
Pedijatrija Danas: Pediatrics Today;Oct2013, Vol. 9 Issue 2, p205
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective -- To underline the fetal kidney toxicity of losartan, an angiotensin receptor blocker (ARB), administered to a woman during pregnancy. Case report -- We describe a male infant, prenatally exposed to losartan from week 32 of gestation, born at term by cesarean section due to maternal hypertension and oligohydramnios. The baby was admitted to the NICU of our hospital for anuria; he required peritoneal dialysis and survived the neonatal period. Presently, the child is 24 months old and is affected by severe chronic renal failure, failure to thrive and persistent hypertension. Conclusions -- Although ARBs are recommended as first line antihypertensive agents, their administration should be avoided during pregnancy, especially from the second trimester onward. Most fetuses, affected by ARB toxicity, progress to death. The few that survive show serious outcomes. If a pregnant woman is under antihypertensive treatment with ARB, this has to be discontinued and replaced as soon as possible, and especially within the second trimester of pregnancy. Obstetricians should also be alerted of the potential risks of ARB administration beyond the first trimester of gestation.
ACCESSION #
91985163

 

Related Articles

  • CONGENITAL TERATOMA IN A RARE CERVICAL LOCATION. HUSARIĆ, Edin; HOTIĆ, Nešad; HALILBAŠIĆ, Amir; RAHMANOVIĆ, Emir; UMIHANIĆ, Šekib // Pedijatrija Danas: Pediatrics Today;Oct2013, Vol. 9 Issue 2, p210 

    Objective -- To underline the fetal kidney toxicity of losartan, an an-giotensin receptor blocker (ARB), administered to a woman during pregnancy. Case report -- We describe a male infant, prenatally exposed to losartan from week 32 of gestation, born at term by cesarean section due to maternal...

  • Telmisartan: A Viewpoint by Wilbert S. Aronow. Aronow, W.S. // Drugs;Dec1998, Vol. 56 Issue 6, p1045 

    Comments on a study on the use of the nonpeptide angiotensin II receptor antagonist telmisartan in the management of hypertension. Details on the dosage and administration of telmisartan; Information on the effectiveness of telmisartan.

  • Angiotensin II receptor antagonists in hypertension. Burnier, Michel; Brunner, Hans R. // Kidney International Supplement;Dec1998, Issue 68, pS-107 

    Examines the efficacy of angiotensin II receptor antagonist for the treatment of hypertension. Route of administration; Therapeutic dosage of angiotensin; Sensitivity of angiotensin.

  • Synthesis and Evaluation of Substituted 1, 2, 4 Triazolinone Derivatives as Novel Angiotensin Ii Receptor Antagonists as Antihypertensive Agents. Parate, Anupama; Sharma, Rajesh; Chaturvedi, Subhash Chandra // Middle East Journal of Scientific Research;11/3/2013, Vol. 17 Issue 2, p237 

    A set of substituted 1, 2, 4 triazolinone derivatives have been synthesized as novel angiotensin II (Ang II) receptor antagonists as antihypertensive agents. Systematic variation of the substituents at the ortho position of N- aryl triazolinones resulted in six novel compounds. The compounds...

  • Synthesis and evaluation of substituted 1,2,4 triazolinone derivatives as novel angiotensin II receptor antagonists as antihypertensive agents. Parate, Anupama; Sharma, Rajesh; Chaturvedi, Subhash Chandra // Der Pharmacia Sinica;2013, Vol. 4 Issue 6, p66 

    A set of substituted 1,2, 4 triazolinone derivatives have been synthesized as novel angiotensin II (Ang II) receptor antagonists as antihypertensive agents. Systematic variation of the substituents at the ortho position of N- aryl triazolinones resulted in six novel compounds. The compounds have...

  • losartan. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p475 

    An encyclopedia entry for "losartan" is presented. It refers to an angiotensin II antagonist drug used as treatment against hypertension or high blood pressure. Side effects of the drug include dizziness, diarrhea and fatigue.

  • An angiotensin II receptor blocker-calcium channel blocker combination prevents cardiovascular events in elderly high-risk hypertensive patients with chronic kidney disease better than high-dose angiotensin II receptor blockade alone. Kim-Mitsuyama, Shokei; Ogawa, Hisao; Matsui, Kunihiko; Jinnouchi, Tomio; Jinnouchi, Hideaki; Arakawa, Kikuo // Kidney International;Jan2013, Vol. 83 Issue 1, p167 

    The OSCAR study was a multicenter, prospective randomized open-label blinded end-point study of 1164 Japanese elderly hypertensive patients comparing the efficacy of angiotensin II receptor blocker (ARB) uptitration to an ARB plus calcium channel blocker (CCB) combination. In this prospective...

  • Journal Club.  // Kidney International;Jan2009, Vol. 75 Issue 2, p133 

    The article presents the findings of various medical studies. One study found that patients with renal dysfunction are less likely to have blood pressure dips at night. Another study showed that combined angiotensin I blocker and vitamin D analogue promotes diabetic nephropathy. Recent research...

  • The effects of Losartan on oxidative stress and inflammation in non-diabetic patients undergoing chronic hemodialysis. KAYABASI, H.; YILMAZ, Z.; SIT, D.; KADIROGLU, A. K.; YILMAZ, E. // European Review for Medical & Pharmacological Sciences;Jan2013, Vol. 17 Issue 2, p235 

    INTRODUCTION: We aimed to evaluate the effects of Losartan, an angiotensin receptor blocker, on serum inflammatory markers, plasma thiol groups, and oxidative stress indexes among patients undergoing hemodialysis (HD) treatment. PATIENTS AND METHODS: Fifty-two end-stage renal disease (ESRD)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics